In the first quarter of 2025, the core brand NIVEA grew organically by 2.5%. Performance was marked by two main influencing factors: A tough comparison base with growth of 12.6% in the first quarter of 2024 and a strategic repositioning in China, with the aim of focusing on premium products, skin care and e-commerce. At the same time, NIVEA achieved outstanding double-digit sales growth in North America and strong performance in the skin care categories globally.
The Eucerin and Aquaphor Derma brands delivered organic sales growth of 11.4%. A key driver of this result was the double-digit sales growth in Emerging Markets due to the launch of Beiersdorf’s breakthrough innovation Epicelline® in more than 15 countries in the region and the further expansion into white spaces. The Derma business generated double-digit growth in North America again, where – only one year after the successful launch of Eucerin Face in the USA – Eucerin hit the shelves with five new Thiamidol-based products.
The La Prairie luxury brand saw a sales decline of 17.5% from January to March against a stronger prior-year baseline. In a challenging market environment in China, the brand faced persistent headwinds in the travel retail business. Beiersdorf responded to this with a significant reduction of stock levels during the first quarter, especially in Hainan. The e-commerce business, however, one of Beiersdorf’s focus areas going forward, delivered positive results with very strong double-digit growth of 24% in China in the first three months of the year. Chantecaille accelerated as expected, with remarkable performance of 15.9% organic sales growth. This was driven by the roll-out in mainland China and the successful expansion across Asia.
The Health Care business, which mainly comprises the Hansaplast and Elastoplast plaster business, delivered organic sales growth of 10.8%. The breakthrough innovation of the Second Skin Protection plaster, launched at the beginning of the year, has already made a positive contribution to this performance.